摘要
目的探讨法莫替丁预防重症哮喘患者发生应激性上消化道出血的临床效果。方法将86例重症哮喘患者随机分为预防组和对照组,预防组口服法莫替丁,观察两组患者有无应激性上消化道出血的临床表现。结果预防组患者应激性上消化道出血的发生率为2.33%(1/43),对照组患者应激性上消化道出血的发生率为13.95%(6/43),两组应激性上消化道出血的发生率比较差异具有显著性(Χ2=3.89,P<0.05)。结论法莫替丁可有效地预防应激性上消化道出血。
Objective To address the clinical effects of famotidine which prevents the excitabilital upper gastrointestinal hemorrhage in the patients of grave asthma. Method Eighty-six patients of grave asthma were diviced into two groups （ the prevented group and the controlled group） at radom. The prevented group took famotidine for oral use. Observe two groups whether have the clinical manifestations of excitability upper gastrointestinal hemorrhage. Results The patients of prevented group have the incidence of excitabilital upper gastrointestinal hemorrhage in 2.33% （ 1/43 ）, and the other group was 13.95 % （6/43）. The result was significant between the two groups （ X^ 2 = 3.84, P 〈 0. 05 ）. Conclusion Famotidine can prevent the excitabilital upper gastrointestinal hemorrhage effeetly.
出处
《辽宁医学杂志》
2006年第6期325-326,共2页
Medical Journal of Liaoning
关键词
法莫替丁
应激性上消化道出血
重症哮喘
预防
famotidine excitabilital upper gastrointestinal hemorrhage grave asthma prevent
